Tuberculosis remains one of the most formidable infectious diseases of our time, killing over a million people annually, disproportionately affecting the poorest communities, and increasingly complicated by drug resistance and diagnostic gaps. Despite decades of effort, the pace of progress is still far too slow to meet global End TB targets. A new review paper co-authored by GlohMed investigator, published in a reputed journal Life Sciences (Elsevier, 2026), makes a strong case for why this needs to change and how.
At the heart of the paper is a shift in perspective: from focusing exclusively on eliminating the bacteria to building and leveraging the host’s own immune and metabolic resilience. The authors explore how the innate immune system can be trained through early exposures like BCG vaccination and how MTB infection hijacks host metabolic pathways to survive inside immune cells. Understanding these mechanisms opens new doors for host-directed therapies that could work alongside or even shorten conventional antibiotic treatment. In parallel, the paper maps an important evolution in diagnostics: from sputum microscopy and culture-based methods toward a new generation of rapid, non-invasive, host/biomarker-driven platforms, including blood transcriptomic signatures, breath-omics, plasma proteomic panels, and smartphone-integrated adherence tools.
The paper also makes a strong case for multi-omics integration and artificial intelligence as the game-changers for TB precision medicine while being honest about the limitations that remain, from infrastructure gaps to the risk of algorithmic bias in low-resource settings. The authors call for standardized workflows, longitudinal validation, and above all, equitable implementation that ensures innovation reaches the communities carrying the heaviest TB burden. GlohMed is proud to be associated with this work and remains committed to research and partnerships that translate cutting-edge science into real world impact.
Citation:
Kurnaz IA, Sonmez E, Edegbene AO, Toldi G, Qasim M, Bhattarai S, Enany S. Host-focused immunity, metabolism, and diagnostic innovation for precision control of tuberculosis globally. Life Sciences. 2026;392:124313. https://doi.org/10.1016/j.lfs.2026.124313